CPT 43239 is one of the most frequently performed procedures in gastroenterology medical billing and coding, representing diagnostic EGD with mucosal biopsy sampling from the upper gastrointestinal tract. It plays a central role in evaluating inflammatory, infectious, and neoplastic conditions of the esophagus, stomach, and duodenum.
Although 43239 is used regularly, it still remains a high-audit and high-denial code because of the documentation lapses, improper combination with 43235, and the lack of consistent reporting of biopsy. Proper coding demands proper connection between clinical indication, biopsy site recording, and pathology reporting to warrant congruent reimbursement by CMS as well as by payer-specific LCD guidelines.
CPT 43239 – Description
Official Definition: “Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple.”
This code describes an upper GI endoscopy in which a flexible scope is passed through the mouth to visualize the esophagus, stomach, and duodenum, with one or more tissue samples obtained using biopsy forceps or similar instruments for pathological analysis.
CPT 43239 is reported once per session regardless of the number of biopsies taken or the number of anatomical sites sampled. The code bundles the diagnostic visualization with the biopsy service. Brushings and washings are not equivalent to biopsy, cytology-only specimens fall under 43235, not 43239.
When to Use CPT 43239
CPT 43239 is used when the physician conducts an upper GI endoscopy and takes tissue samples using forceps or other devices to be pathologically examined. It is the diagnostic code of workhorse in the vast majority of cases of upper GI biopsy.
Typical clinical signs are:
- GERD with suspected esophagitis or Barrett’s esophagus surveillance.
- Evaluation of chronic gastritis, H. pylori testing, or atrophic gastritis.
- Peptic ulcer disease and duodenal ulcer biopsy for malignancy exclusion.
- Celiac disease workup with duodenal biopsies.
- Evaluation of dysphagia, dyspepsia, or unexplained upper GI symptoms.
- Iron deficiency anemia workup or occult GI bleeding evaluation.
- Surveillance of known upper GI malignancy or premalignant lesions.
Do not report 43239 for:
- Diagnostic EGD without tissue biopsy (use 43235, even if brushings or washings were taken).
- EUS-guided fine needle aspiration (use 43238 or 43242).
- Polyp or lesion removal by snare, hot biopsy forceps, or cold snare (use 43250 or 43251).
- Endoscopic mucosal resection (use 43254).
Therapeutic measures like bleeding, dilation, or removing a foreign body (use corresponding therapeutic code).
Reimbursement Insights For CPT Code 43239
CPT 43239 reimbursement depends on the type of payer and setting:
- The facility settings tend to pay less in terms of physician fee component.
- Non-facility settings reflect higher practice expense RVUs
- Commercial payers vary based on contracted rates
- Pathology services are separately reimbursable
- Global period: 0-day service.
Applicable Modifiers For CPT Code 43239
Modifiers can shed some light on billing situations:
- Modifier 22 – Increased procedural services when the biopsy required significantly greater work than usual; supporting documentation required.
- Modifier 52 – Reduced services when the scope could not be advanced to the duodenum despite a good-faith attempt.
- Modifier 53 – Discontinued procedure due to patient-related complications before completion.
- Modifier 59 or XS – Used when 43239 is reported with a therapeutic EGD code performed at a distinct anatomic site during the same session; documentation must clearly establish different sites.
- Modifier 74 – Discontinued outpatient procedure after anesthesia administration (ASC/hospital outpatient use).
- Modifier 51 – Multiple procedures when 43239 is performed with another unrelated procedure on the same day.
Component modifiers (26/TC) do not apply to 43239 as it is a global surgical code. Always confirm payer-specific modifier acceptance before submission.
Documentation Requirements For CPT Code 43239
Accurate documentation will uphold medical necessity and safeguard against denials. Sources of procedure notes ought to contain:
- ICD-10 diagnosis and clinical indication in favor of the LCD.
- Pre-procedure consent, sedation plan, and vital signs.
- Scope type, route (transoral), and extent of examination reached (second portion of duodenum).
- Results in esophagus, stomach and duodenum using anatomical landmarks.
- Biopsy instrument used (cold forceps, hot forceps, etc.).
- Number of biopsies taken and each anatomical site sampled.
- Specimen handling and pathology destination (e.g., “specimens in separate jars sent to pathology”).
- • Sedation time and medications, with independent observer when required for Medicare.
- Post-procedure status, complications, and recovery notes.
- Signed procedure report by the gastroenterologist who performed the procedure.
Example Scenarios Under CPT Code 43239
- Scenario 1: A gastroenterologist performs an EGD with two cold forceps biopsies of the gastric antrum for H. pylori evaluation. → Report CPT 43239 once.
- Scenario 2: Barrett’s esophagus surveillance with four-quadrant biopsies from three levels plus biopsy of a gastric nodule. → Report CPT 43239 once; multiple biopsies at multiple sites are bundled into a single unit.
- Scenario 3: EGD with brushings of the gastric cardia but no forceps biopsy. → Do not report 43239; report 43235 since cytology brushings are included in the diagnostic EGD code.
- Scenario 4: EGD with duodenal biopsies for celiac workup plus balloon dilation of an esophageal stricture. → Report 43249 (dilation) and 43239-59 (biopsy at distinct site) with clear documentation.
BillingFreedom Known For Gastroenterology Medical Billing Built on High Claim Accuracy Standards
In BillingFreedom, our gastroenterology medical billing and coding processes are focused to achieve 98%+ first-pass claim acceptance with denial rates always kept at less than 1% in biopsy-intensive endoscopy services. This performance level is achieved through structured coding validation for CPT 43239 and related EGD procedures, ensuring every claim aligns with payer-specific LCD policies and CMS documentation standards.
Our coding specialists actively manage the full EGD and biopsy ecosystem, with strict control over:
- Rule enforcement of single-session biopsy (independent of the number of specimens)
- Correct differentiation between forceps biopsy, brushings, and EUS-guided sampling
- Edits and compliance with NCCI in surgical endoscopy.
- Modifier 59 / XS application for distinct procedural services
- Pathology alignment with CPT 88305 and specimen-level documentation
- Moderate sedation coding validation (G0500 vs 99152/99153)
This structured approach has led to a high acceptance rate for the Gastroenterology medical billing workflow (~98%), ensuring minimal rework and faster reimbursement cycles. Claim corrections and reprocessing remain under 2% of total submissions, directly improving revenue predictability for gastroenterology practices.
Our team keeps abreast of CMS changes, MAC LCD changes, AMA CPT Assistant directions, and AAPC coding changes to maintain all coding determinations in line with the present payers regulations. This minimises audit exposure and avoids typical denial causes like duplicate billing, lack of biopsy justification or incorrect pairing of procedures.
As a result, gastroenterology practices working with BillingFreedom consistently experience:
- Higher net collections due to reduced claim rejections
- Faster accounts receivable cycles (under 28 days average)
- Improved reimbursement stability across endoscopy-heavy volumes
- Lower administrative burden on internal billing teams
BillingFreedom still extends its services to gastroenterology groups and ambulatory endoscopy facilities with a developed revenue integrity model designed to support high endoscopic volume EGDs, biopsy, and more.
For more details about our exceptional Gastroenterology billing services, please don't hesitate to contact us via email at info@billingfreedom.com or call us at +1 (855) 415-3472.
Your financial tranquility is our priority!
Related ICD-10-CM Codes
ICD-10-CM Codes
C15.4 - Malignant neoplasm of middle third of esophagus
C15.5 - Malignant neoplasm of lower third of esophagus
C15.8 - Malignant neoplasm of overlapping sites of esophagus
C15.9 - Malignant neoplasm of esophagus, unspecified
C16.1 - Malignant neoplasm of fundus of stomach
C16.2 - Malignant neoplasm of body of stomach
C16.4 - Malignant neoplasm of pylorus
C16.5 - Malignant neoplasm of lesser curvature of stomach, unspecified
C16.8 - Malignant neoplasm of overlapping sites of stomach
C16.9 - Malignant neoplasm of stomach, unspecified
C17.1 - Malignant neoplasm of jejunum
C17.9 - Malignant neoplasm of small intestine, unspecified
C26.9 - Malignant neoplasm of ill-defined sites within the digestive system
C78.4 - Secondary malignant neoplasm of small intestine
C78.7 - Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.80 - Secondary malignant neoplasm of unspecified digestive organ
C78.89 - Secondary malignant neoplasm of other digestive organs
C7A.010 - Malignant carcinoid tumor of the duodenum
C7A.011 - Malignant carcinoid tumor of the jejunum
C7A.092 - Malignant carcinoid tumor of the stomach
C7A.098 - Malignant carcinoid tumors of other sites
D00.1 - Carcinoma in situ of esophagus
D00.2 - Carcinoma in situ of stomach
D13.1 - Benign neoplasm of stomach
D13.2 - Benign neoplasm of duodenum
D13.30 - Benign neoplasm of unspecified part of small intestine
D13.39 - Benign neoplasm of other parts of small intestine
D13.99 - Benign neoplasm of ill-defined sites within the digestive system
D3A.010 - Benign carcinoid tumor of the duodenum
D3A.012 - Benign carcinoid tumor of the ileum
D3A.092 - Benign carcinoid tumor of the stomach
D3A.094 - Benign carcinoid tumor of the foregut, unspecified
D3A.098 - Benign carcinoid tumors of other sites
D64.9 - Anemia, unspecified
F50.010 - Anorexia nervosa, restricting type, mild
F50.011 - Anorexia nervosa, restricting type, moderate
F50.012 - Anorexia nervosa, restricting type, severe
F50.013 - Anorexia nervosa, restricting type, extreme
F50.014 - Anorexia nervosa, restricting type, in remission
F50.019 - Anorexia nervosa, restricting type, unspecified
F50.020 - Anorexia nervosa, binge eating/purging type, mild
F50.021 - Anorexia nervosa, binge eating/purging type, moderate
F50.022 - Anorexia nervosa, binge eating/purging type, severe
F50.023 - Anorexia nervosa, binge eating/purging type, extreme
F50.024 - Anorexia nervosa, binge eating/purging type, in remission
F50.029 - Anorexia nervosa, binge eating/purging type, unspecified
F50.20 - Bulimia nervosa, unspecified
F50.21 - Bulimia nervosa, mild
F50.22 - Bulimia nervosa, moderate
F50.23 - Bulimia nervosa, severe
F50.24 - Bulimia nervosa, extreme
F50.25 - Bulimia nervosa, in remission
F50.810 - Binge eating disorder, mild
F50.811 - Binge eating disorder, moderate
F50.812 - Binge eating disorder, severe
F50.813 - Binge eating disorder, extreme
F50.814 - Binge eating disorder, in remission
F50.819 - Binge eating disorder, unspecified
F50.83 - Pica in adults
F50.84 - Rumination disorder in adults
F98.21 - Rumination disorder of infancy and childhood
I85.10 - Secondary esophageal varices without bleeding
J86.0 - Pyothorax with fistula
K20.0 - Eosinophilic esophagitis
K21.9 - Gastro-esophageal reflux disease without esophagitis
K22.11 - Ulcer of esophagus with bleeding
K22.2 - Esophageal obstruction
K22.4 - Dyskinesia of esophagus
K22.6 - Gastro-esophageal laceration-hemorrhage syndrome
K22.89 - Other specified disease of esophagus
K23 - Disorders of esophagus in diseases classified elsewhere
K25.0 - Acute gastric ulcer with hemorrhage
K25.3 - Acute gastric ulcer without hemorrhage or perforation
K25.4 - Chronic or unspecified gastric ulcer with hemorrhage
K25.5 - Chronic or unspecified gastric ulcer with perforation
K25.6 - Chronic or unspecified gastric ulcer with both hemorrhage and perforation
K25.9 - Gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation
K26.0 - Acute duodenal ulcer with hemorrhage
K26.1 - Acute duodenal ulcer with perforation
K26.2 - Acute duodenal ulcer with both hemorrhage and perforation
K26.4 - Chronic or unspecified duodenal ulcer with hemorrhage
K26.5 - Chronic or unspecified duodenal ulcer with perforation
K26.6 - Chronic or unspecified duodenal ulcer with both hemorrhage and perforation
K26.7 - Chronic duodenal ulcer without hemorrhage or perforation
K27.0 - Acute peptic ulcer, site unspecified, with hemorrhage
K27.1 - Acute peptic ulcer, site unspecified, with perforation
K27.2 - Acute peptic ulcer, site unspecified, with both hemorrhage and perforation
K27.3 - Acute peptic ulcer, site unspecified, without hemorrhage or perforation
K27.5 - Chronic or unspecified peptic ulcer, site unspecified, with perforation
K27.6 - Chronic or unspecified peptic ulcer, site unspecified, with both hemorrhage and perforation
K27.7 - Chronic peptic ulcer, site unspecified, without hemorrhage or perforation
K27.9 - Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation
K28.1 - Acute gastrojejunal ulcer with perforation
K28.2 - Acute gastrojejunal ulcer with both hemorrhage and perforation
K28.3 - Acute gastrojejunal ulcer without hemorrhage or perforation
K28.4 - Chronic or unspecified gastrojejunal ulcer with hemorrhage
K28.6 - Chronic or unspecified gastrojejunal ulcer with both hemorrhage and perforation
K28.7 - Chronic gastrojejunal ulcer without hemorrhage or perforation
K28.9 - Gastrojejunal ulcer, unspecified as acute or chronic, without hemorrhage or perforation
K29.01 - Acute gastritis with bleeding
K29.21 - Alcoholic gastritis with bleeding
K29.31 - Chronic superficial gastritis with bleeding
K29.61 - Other gastritis with bleeding
K29.71 - Gastritis, unspecified, with bleeding
K29.91 - Gastroduodenitis, unspecified, with bleeding
K30 - Functional dyspepsia
K31.0 - Acute dilatation of stomach
K31.3 - Pylorospasm, not elsewhere classified
K31.5 - Obstruction of duodenum
K31.6 - Fistula of stomach and duodenum
K31.7 - Polyp of stomach and duodenum
K31.811 - Angiodysplasia of stomach and duodenum with bleeding
K31.819 - Angiodysplasia of stomach and duodenum without bleeding
K31.82 - Dieulafoy lesion (hemorrhagic) of stomach and duodenum
K31.84 - Gastroparesis
K31.89 - Other diseases of stomach and duodenum
K31.9 - Disease of stomach and duodenum, unspecified
K31.A0 - Gastric intestinal metaplasia, unspecified
K31.A11 - Gastric intestinal metaplasia without dysplasia, involving the antrum
K31.A12 - Gastric intestinal metaplasia without dysplasia, involving the body (corpus)
K31.A13 - Gastric intestinal metaplasia without dysplasia, involving the fundus
K31.A14 - Gastric intestinal metaplasia without dysplasia, involving the cardia
K31.A15 - Gastric intestinal metaplasia without dysplasia, involving multiple sites
K31.A19 - Gastric intestinal metaplasia without dysplasia, unspecified site
K31.A21 - Gastric intestinal metaplasia with low grade dysplasia
K31.A22 - Gastric intestinal metaplasia with high grade dysplasia
K31.A29 - Gastric intestinal metaplasia with dysplasia, unspecified
K44.0 - Diaphragmatic hernia with obstruction, without gangrene
K44.9 - Diaphragmatic hernia without obstruction or gangrene
K52.1 - Toxic gastroenteritis and colitis
K52.29 - Other allergic and dietetic gastroenteritis and colitis
K52.81 - Eosinophilic gastritis or gastroenteritis
K52.89 - Other specified noninfective gastroenteritis and colitis
K52.9 - Noninfective gastroenteritis and colitis, unspecified
K56.600 - Partial intestinal obstruction, unspecified as to cause
K56.601 - Complete intestinal obstruction, unspecified as to cause
K56.609 - Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction
K63.3 - Ulcer of intestine
K63.4 - Enteroptosis
K63.81 - Dieulafoy lesion of intestine
K63.8211 - Small intestinal bacterial overgrowth, hydrogen-subtype
K63.8212 - Small intestinal bacterial overgrowth, hydrogen sulfide-subtype
K63.8219 - Small intestinal bacterial overgrowth, unspecified
K63.89 - Other specified diseases of intestine
K70.2 - Alcoholic fibrosis and sclerosis of liver
K70.30 - Alcoholic cirrhosis of liver without ascites
K70.31 - Alcoholic cirrhosis of liver with ascites
K70.40 - Alcoholic hepatic failure without coma
K70.41 - Alcoholic hepatic failure with coma
K70.9 - Alcoholic liver disease, unspecified
K73.0 - Chronic persistent hepatitis, not elsewhere classified
K73.1 - Chronic lobular hepatitis, not elsewhere classified
K73.2 - Chronic active hepatitis, not elsewhere classified
K73.8 - Other chronic hepatitis, not elsewhere classified
K74.00 - Hepatic fibrosis, unspecified
K74.01 - Hepatic fibrosis, early fibrosis
K74.02 - Hepatic fibrosis, advanced fibrosis
K74.3 - Primary biliary cirrhosis
K74.4 - Secondary biliary cirrhosis
K74.5 - Biliary cirrhosis, unspecified
K74.60 - Unspecified cirrhosis of liver
K74.69 - Other cirrhosis of liver
K75.81 - Nonalcoholic steatohepatitis (NASH)
K76.0 - Fatty (change of) liver, not elsewhere classified
K76.89 - Other specified diseases of liver
K86.0 - Alcohol-induced chronic pancreatitis
K86.1 - Other chronic pancreatitis
K90.2 - Blind loop syndrome, not elsewhere classified
K90.89 - Other intestinal malabsorption
K91.2 - Postsurgical malabsorption, not elsewhere classified
K92.0 - Hematemesis
K92.1 - Melena
K92.2 - Gastrointestinal hemorrhage, unspecified
Q26.5 - Anomalous portal venous connection
Q26.6 - Portal vein-hepatic artery fistula
Q27.33 - Arteriovenous malformation of digestive system vessel
Q39.5 - Congenital dilatation of esophagus
Q39.6 - Congenital diverticulum of esophagus
Q39.8 - Other congenital malformations of esophagus
Q39.9 - Congenital malformation of esophagus, unspecified
Q40.0 - Congenital hypertrophic pyloric stenosis
Q40.1 - Congenital hiatus hernia
Q40.2 - Other specified congenital malformations of stomach
Q40.3 - Congenital malformation of stomach, unspecified
Q85.82 - Other Cowden syndrome
Q85.83 - Von Hippel-Lindau syndrome
Q85.89 - Other phakomatoses, not elsewhere classified
R07.0 - Pain in throat
R10.10 - Upper abdominal pain, unspecified
R10.20 - Pelvic and perineal pain unspecified side
R10.21 - Pelvic and perineal pain right side
R10.22 - Pelvic and perineal pain left side
R10.23 - Pelvic and perineal pain bilateral
R10.24 - Suprapubic pain
R10.30 - Lower abdominal pain, unspecified
R10.85 - Abdominal pain of multiple sites
R11.16 - Cannabis hyperemesis syndrome
R12 - Heartburn
R13.11 - Dysphagia, oral phase
R13.13 - Dysphagia, pharyngeal phase
R13.14 - Dysphagia, pharyngoesophageal phase
R13.19 - Other dysphagia
R14.0 - Abdominal distension (gaseous)
R14.1 - Gas pain
R14.2 - Eructation
R14.3 - Flatulence
R19.11 - Absent bowel sounds
R19.12 - Hyperactive bowel sounds
R19.15 - Other abnormal bowel sounds
R19.4 - Change in bowel habit
R19.5 - Other fecal abnormalities
R19.8 - Other specified symptoms and signs involving the digestive system and abdomen
R63.4 - Abnormal weight loss
R63.6 - Underweight
T18.3XXD - Foreign body in small intestine, subsequent encounter
T18.3XXS - Foreign body in small intestine, sequela
T18.8XXD - Foreign body in other parts of alimentary tract, subsequent encounter
T18.9XXD - Foreign body of alimentary tract, part unspecified, subsequent encounter
T18.9XXS - Foreign body of alimentary tract, part unspecified, sequela
T54.1X1D - Toxic effect of other corrosive organic compounds, accidental (unintentional), subsequent encounter
T54.1X1S - Toxic effect of other corrosive organic compounds, accidental (unintentional), sequela
T54.1X2D - Toxic effect of other corrosive organic compounds, intentional self-harm, subsequent encounter
T54.1X2S - Toxic effect of other corrosive organic compounds, intentional self-harm, sequela
T54.1X3D - Toxic effect of other corrosive organic compounds, assault, subsequent encounter
T54.1X3S - Toxic effect of other corrosive organic compounds, assault, sequela
T54.1X4D - Toxic effect of other corrosive organic compounds, undetermined, subsequent encounter
T54.1X4S - Toxic effect of other corrosive organic compounds, undetermined, sequela
T54.2X1D - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), subsequent encounter
T54.2X1S - Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), sequela
T54.2X2D - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, subsequent encounter
T54.2X2S - Toxic effect of corrosive acids and acid-like substances, intentional self-harm, sequela
T54.2X3D - Toxic effect of corrosive acids and acid-like substances, assault, subsequent encounter
T54.2X3S - Toxic effect of corrosive acids and acid-like substances, assault, sequela
T54.2X4D - Toxic effect of corrosive acids and acid-like substances, undetermined, subsequent encounter
T54.2X4S - Toxic effect of corrosive acids and acid-like substances, undetermined, sequela
T54.3X1D - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), subsequent encounter
T54.3X1S - Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), sequela
T54.3X2D - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, subsequent encounter
T54.3X2S - Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, sequela
T54.3X3D - Toxic effect of corrosive alkalis and alkali-like substances, assault, subsequent encounter
T54.3X3S - Toxic effect of corrosive alkalis and alkali-like substances, assault, sequela
T54.3X4D - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, subsequent encounter
T54.3X4S - Toxic effect of corrosive alkalis and alkali-like substances, undetermined, sequela
T54.91XD - Toxic effect of unspecified corrosive substance, accidental (unintentional), subsequent encounter
T54.91XS - Toxic effect of unspecified corrosive substance, accidental (unintentional), sequela
T54.92XD - Toxic effect of unspecified corrosive substance, intentional self-harm, subsequent encounter
T54.92XS - Toxic effect of unspecified corrosive substance, intentional self-harm, sequela
T54.93XD - Toxic effect of unspecified corrosive substance, assault, subsequent encounter
T54.93XS - Toxic effect of unspecified corrosive substance, assault, sequela
T54.94XD - Toxic effect of unspecified corrosive substance, undetermined, subsequent encounter
T54.94XS - Toxic effect of unspecified corrosive substance, undetermined, sequela
T57.1X1D - Toxic effect of phosphorus and its compounds, accidental (unintentional), subsequent encounter
T57.1X1S - Toxic effect of phosphorus and its compounds, accidental (unintentional), sequela
T57.1X2D - Toxic effect of phosphorus and its compounds, intentional self-harm, subsequent encounter
T57.1X2S - Toxic effect of phosphorus and its compounds, intentional self-harm, sequela
T57.1X3D - Toxic effect of phosphorus and its compounds, assault, subsequent encounter
T57.1X3S - Toxic effect of phosphorus and its compounds, assault, sequela
T57.1X4D - Toxic effect of phosphorus and its compounds, undetermined, subsequent encounter
T57.1X4S - Toxic effect of phosphorus and its compounds, undetermined, sequela
T65.5X1D - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), subsequent encounter
T65.5X1S - Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), sequela
T65.5X2D - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, subsequent encounter
T65.5X2S - Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, sequela
T65.5X3D - Toxic effect of nitroglycerin and other nitric acids and esters, assault, subsequent encounter
T65.5X3S - Toxic effect of nitroglycerin and other nitric acids and esters, assault, sequela
T65.5X4D - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, subsequent encounter
T65.5X4S - Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, sequela
T73.0XXD - Starvation, subsequent encounter
T73.0XXS - Starvation, sequela
Z03.6 - Encounter for observation for suspected toxic effect from ingested substance ruled out
Z03.89 - Encounter for observation for other suspected diseases and conditions ruled out
Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
Z15.068 - Genetic susceptibility to other malignant neoplasm of digestive system
Z83.710 - Family history of adenomatous and serrated polyps
Z83.711 - Family history of hyperplastic colon polyps
Z83.718 - Family history of other colon polyps
Z83.719 - Family history of colon polyps, unspecified
Z83.79 - Family history of other diseases of the digestive system
Z85.00 - Personal history of malignant neoplasm of unspecified digestive organ
Z86.003 - Personal history of in-situ neoplasm of oral cavity, esophagus and stomach
Z86.004 - Personal history of in-situ neoplasm of other and unspecified digestive organs
Z87.11 - Personal history of peptic ulcer disease
Z87.19 - Personal history of other diseases of the digestive system
Related CPT Codes
CPT Codes
43235 - Complete Billing & Coding Guide for Diagnostic Esophagogastroduodenoscopy (EGD)
43236 - Complete Billing & Coding Guide for EGD with Directed Submucosal Injection
43237 - Complete Billing & Coding Guide for EGD with Endoscopic Ultrasound Examination
43238 - Complete Billing & Coding Guide for EGD with EUS-Guided Fine Needle Aspiration
43244 - Complete Billing & Coding Guide for EGD with Band Ligation of Esophageal and Gastric Varices
43245 - Complete Billing & Coding Guide for EGD with Dilation of Gastric or Duodenal Strictures
43248 - Complete Billing & Coding Guide for EGD with Guidewire-Assisted Esophageal Dilation
43249 - Complete Billing & Coding Guide for EGD With Esophageal Balloon Dilation
43255 - Complete Billing & Coding Guide for EGD With Control of Bleeding